SCHEMBL17325500

SCHEMBL17325500

CCN1c2ccccc2SC1/C=C/c1ccc(O)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 2/20 0.44
▸ APP P05067 4/20 0.44
▸ MAPT P10636 3/20 0.44
▸ TTR P02766 1/20 0.43
▸ CYP2D6 P10635 3/20 0.43
▸ NFE2L2 Q16236 3/20 0.43
▸ ALOX5 P09917 3/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ MAOB P27338 2/20 0.43
▸ KDM1A O60341 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ NFKB1 P19838 2/20 0.43
▸ HSD11B1 P28845 2/20 0.43
▸ STAT3 P40763 2/20 0.43
▸ NFKB2 Q00653 2/20 0.43
▸ RELA Q04206 2/20 0.43
▸ PTGS1 P23219 2/20 0.43
▸ PTGS2 P35354 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29249440 0.86 APP (0.47) TYRAPPMAPTTTRCYP2D6
SCHEMBL29815053 0.85 NFE2L2 (0.48) TYRAPPMAPTTTRCYP2D6
SCHEMBL29815420 0.74 ALOX5 (0.43) MAPTCYP2D6ALOX5CYP2C9CYP1A2
SCHEMBL29815326 0.72 LCK (0.41) MAPTTTRALOX5CYP2C9HSD17B10
SCHEMBL31231844 0.71 APP (0.52) APPMAPTCYP2C9HSD17B10KDM1A
SCHEMBL29815216 0.69 KDM1A (0.38) NFE2L2KDM1APTGS1MEN1MMP9
SCHEMBL11460156 0.69 BCHE (0.34) MAPTMEN1USP2ALDH1A1LMNA
SCHEMBL17732299 0.68 TTR (0.85) TYRAPPMAPTTTRCYP2D6
SCHEMBL671150 0.68 TTR (0.85) TYRAPPMAPTTTRCYP2D6
SCHEMBL671149 0.68 TTR (0.85) TYRAPPMAPTTTRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150353515-A1 Novel analogs of resveratrol HUANG WEN-HSIN (TW) 2015-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353515-A1 Novel analogs of resveratrol KDR, FLT1, SIRT1 TYR 3612/4885APP 1723/4885MAPT 1041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback